Immediate Impact
5 from Science/Nature 63 standout
Citing Papers
Cystic fibrosis
2024 Standout
Dendritic Polymer‐Based Nanomedicines Remodel the Tumor Stroma: Improve Drug Penetration and Enhance Antitumor Immune Response
2024 Standout
Works of Jonathan H. Rayment being referenced
Phase 3 Open-Label Clinical Trial of Elexacaftor/Tezacaftor/Ivacaftor in Children Aged 2–5 Years with Cystic Fibrosis and at Least One F508del Allele
2023 Standout
Addressing the Role of Cell Adhesion in Tumor Cell Dormancy
2006
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| Jonathan H. Rayment | 360 | 79 | 144 | 34 | 566 | |
| Long-Hai Zhao | 177 | 46 | 61 | 14 | 544 | |
| Balduin Lucké | 192 | 100 | 67 | 16 | 552 | |
| David Mummy | 254 | 28 | 205 | 33 | 526 | |
| Rafael Firszt | 92 | 166 | 121 | 21 | 512 | |
| J. McRae | 205 | 77 | 24 | 27 | 525 | |
| Mohammed Zaki | 179 | 108 | 76 | 43 | 599 | |
| Enno Stranzinger | 154 | 183 | 78 | 35 | 482 | |
| Julius Renne | 303 | 91 | 191 | 33 | 632 | |
| T Heckscher | 352 | 34 | 51 | 16 | 540 | |
| S. Ramaiah Ganti | 99 | 178 | 18 | 33 | 566 |
All Works
Login with ORCID to disown or claim papers
Loading papers...